8:30 – 9:15
May 15th
Check in
9:15 – 9:30
May 15th
Genesis Pharma Symposium
“Updates in the management of Acute Hepatic Porphyria”
Moderator: Ciprian Tomuleasa M.D.
Oncological Institute “Prof. Dr. Ion Chiricuţă”, Cluj-Napoca
“From scientific evidence to clinical experience”
Anamaria Bancos M.D.
Clinical County Emergency Hospital Bistrita, Bistrita-Nasaud
Q&A
- Ciprian Tomuleasa M.D.
Oncological Institute “Prof. Dr. Ion Chiricuţă”, Cluj-Napoca - Anamaria Bancos M. D.
Clinical County Emergency Hospital Bistrita, Bistrita-Nasaud
9:30 – 9:50
May 15th
Sobi Symposium
Ioana Codruţa Rus M.D., PhD
Oncological Institute “Prof. Dr. Ion Chiricuţă”, Cluj-Napoca Doptelet in chronic ITP: timing and criteria for switch
9:50 – 10:10
May 15th
Takeda Symposium
Alok Srivastava MD, FRACP, FRCPA, FRCP
Christian Medical College Vellore, Tamil Nadu, India
Advancing Hemophilia Care: From Guidelines to Personalized Therapy
10:10 – 11:15
May 15th
Johnson & Johnson Symposiums
10:10 – 10:35
May 15th
Vasilica Mariana M.D.
Fundeni Clinical Institute, Bucharest, Romania
The benefits of I+V treatment in first-line CLL patients” – 25 minute
10:35 – 10:55
May 15th
Catana Alina Camelia M.D.
The County Emergency Clinical Hospital Of Sibiu
Quadruple therapy in newly diagnosed Multiple Myeloma eligible for transplant
10:55 – 11:15
May 15th
Tomuleasa Ciprian M.D.
Oncological Institute “Prof. Dr. Ion Chiricuţă”, Cluj-Napoca
Bispecifics as novel agents in Multiple Myeloma treatment management
11:15 – 12:00
May 15th
Coffee break + Q&A
Translational research session
12:00 – 12:30
May 15th
Laura Belver, PhD
Josel Carreras Institute, Barcelona, Spain
12:30 – 13:00
May 15th
Adrian Gottschlich, M.D.
Adrian Gottschlich, M.D. University of München, München, Germany
13:00 – 13:30
May 15th
Paula Tabares, PhD
University of Würzburg, Würzburg, Germany
13:30 – 14:00
May 15th
Dr. Lukasz Gondek, MD, PhD
Johns Hopkins University, Baltimore, USA
14:00 – 15:10
May 15th
Lunch Break
15:10 – 15:30
May 15th
Astellas Symposium
Tomuleasa Ciprian M.D.
Treatment of relapsed/refractory acute myeloid leukemia with FLT3+ mutation (LMA R/R FLT3MUT+)
Lymphoma and myeloma session
15:30 – 16:00
May 15th
Despina Fotiou, MD
National and Kapodistrian University of Athens, Athens, Greece
16:00 – 17:00
May 15th
Ivan Borrello, M.D.
Johns Hopkins University, Baltimore, USA
17:00 – 17:30
May 15th
Ian Ghezzi, PhD
Heidelberg University, Heidelberg, Germany
17:30 – 18:00
May 15th
Novartis Symposium
Alina Tănase, MD
Fundeni Clinical Institute, Bucharest, Romania
18:00 – 18:20
May 15th
Mihnea Zdrenghea M.D.
Pfizer sympozium
Oncological Institute “Prof. Dr. Ion Chiricuţă”, Cluj-Napoca
18:20 – 19:00
May 15th
Genesis Pharma Symposium
Moderator: Mihnea Zdrenghea M.D.
Oncological Institute “Prof. Dr. Ion Chiricuţă”, Cluj-Napoca
“TTR Amyloidosis”
“A new perspective in the management of hATTR amyloidosis”
Ioana Codruţa Rus M.D.
“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca
,,Clinical evidence in the treatment of hATTR”
Tőrők-Vistai Tünde M.D.
“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca
Q&A
Mihnea Zdrenghea M.D.
“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca
Tőrők-Vistai Tünde
“Prof. Dr. Ion Chiricuţă” Oncology Institute, Cluj-Napoca
